Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,947,654,982
+$159,788,753 QoQ
Shares Held
3,920,953
-2.1% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
2.47%
of 13F equity value
Holder Rank
#11
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $4,031,464,727 across 23 Biotechnology names. VRTX ranks #1 (48.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,920,953 | $1,947,654,982 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,859,172 | $1,159,268,108 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
580,187 | $174,653,692 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
291,805 | $92,236,641 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
239,490 | $58,619,966 | |
| 6 | VCEL |
Vericel Corp
|
1,200,239 | $53,398,633 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
443,636 | $51,936,466 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
434,102 | $48,198,345 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,947,654,982 | 3,920,953 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,787,866,229 | 4,003,821 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,828,638,893 | 4,033,525 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,614,390,209 | 4,122,128 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,697,715,885 | 3,813,378 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,817,265,835 | 3,748,331 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,519,302,129 | 3,772,789 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,426,964,966 | 3,068,214 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,472,798,390 | 3,142,171 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,300,190,007 | 3,110,428 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,275,539,929 | 3,134,852 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,100,064,361 | 3,163,468 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,152,614,341 | 3,275,310 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,062,304,504 | 3,371,646 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,085,573,112 | 3,759,170 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,204,020,240 | 4,158,390 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,256,145,427 | 4,457,736 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $1,667,343,331 | 6,389,023 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,457,101,558 | 6,635,253 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,270,816,888 | 7,005,992 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $413,517,522 | 2,050,873 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $214,030 | 996 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,959 | 186 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $170,347 | 626 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $135,574 | 467 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $120,878 | 508 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||